Dr. Sarah Paraghamian
Claim this profileTufts Medical Center
Studies Peritoneal Tumors
Studies Ovarian Cancer
5 reported clinical trials
9 drugs studied
Area of expertise
1Peritoneal Tumors
Stage III
Stage IV
2Ovarian Cancer
Stage III
Stage IV
Affiliated Hospitals
Clinical Trials Sarah Paraghamian is currently running
Mirvetuximab + Bevacizumab
for Ovarian Cancer
GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.
Recruiting2 awards Phase 3
Selinexor Maintenance Therapy
for Endometrial Cancer
The purpose of this study is to evaluate the efficacy and safety of selinexor as a maintenance treatment in patients with p53 wt endometrial carcinoma (EC), who have achieved a partial response (PR) or complete response (CR) (per Response Evaluation Criteria in Solid Tumors version 1.1 \[RECIST v 1.1\]) after completing at least 12 weeks of platinum-based therapy. A total of 220 participants will be enrolled in the study and randomized in a 1:1 ratio to maintenance therapy with either selinexor or placebo.
Recruiting1 award Phase 32 criteria
More about Sarah Paraghamian
Clinical Trial Related1 year of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Sarah Paraghamian has experience with
- Oregovomab
- Paclitaxel
- Carboplatin
- Abemaciclib
- Letrozole
- Selinexor
Breakdown of trials Sarah Paraghamian has run
Peritoneal Tumors
Ovarian Cancer
Fallopian Tube Cancer
Peritoneal Neoplasm
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sarah Paraghamian specialize in?
Sarah Paraghamian focuses on Peritoneal Tumors and Ovarian Cancer. In particular, much of their work with Peritoneal Tumors has involved Stage III patients, or patients who are Stage IV.
Is Sarah Paraghamian currently recruiting for clinical trials?
Yes, Sarah Paraghamian is currently recruiting for 2 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Sarah Paraghamian has studied deeply?
Yes, Sarah Paraghamian has studied treatments such as Oregovomab, Paclitaxel, Carboplatin.
What is the best way to schedule an appointment with Sarah Paraghamian?
Apply for one of the trials that Sarah Paraghamian is conducting.
What is the office address of Sarah Paraghamian?
The office of Sarah Paraghamian is located at: Tufts Medical Center, Boston, Massachusetts 02111 United States. This is the address for their practice at the Tufts Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.